Safety of Abiraterone Acetate Administration in Elderly Patients Receiving Peritoneal Dialysis with Castration-Resistant Prostate Cancer: Two Case Reports-Reference-Cited by-同舟云学术

Safety of Abiraterone Acetate Administration in Elderly Patients Receiving Peritoneal Dialysis with Castration-Resistant Prostate Cancer: Two Case Reports

Published:2019-04-26 Issue:2 Volume:86 Page:135-138
ISSN:1345-4676
Container-title:Journal of Nippon Medical School
language:en
Short-container-title:J Nippon Med Sch

Author:

Kimata Ryoji¹,Tomita Yuji¹,Kondo Yukihiro²

Affiliation:

1. Department of Urology, Nippon Medical School Musashi Kosugi Hospital

2. Department of Urology, Nippon Medical School

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jnms/86/2/86_JNMS.2019_86-211/_pdf

Reference6 articles.

1. 1. De Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI: Abiraterone and increased survival in metastatic prostate cancer. N Eng J Med 2011; 364: 1995-2005.

2. 2. Ryan CJ, Amith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE: Abiraterone in metastatic prostate cancer without previous chemotherapy. N Eng J Med 2013; 368: 138-148.

3. 3. Tsang ES, de Haan M, Eigl BJ: A case report of enzalutamide administration in a dialysis-dependent patient with castration-resistant prostate cancer. J Oncol Pharm Pract 2018; 24: 143-145.

4. 4. Mulders PF, Molina A, Marberger M, Saad F, Higano CS, Chi KN, Li J, Kheoh T, Haqq CM, Fizazi K: Efficacy and safety of abiraterone acetate in an elderly patient subgroup (aged 75 and older) with metastatic castration-resistant prostate cancer after docetaxel based chemotherapy. Eur Urol 2014; 65: 875-883.

5. 5. Matsubara N, Uemura H, Satoh T, Suzuki H, Nishiyama T, Uemura H, Hashine K, Imanaka K, Ozono S, Akaza H: A phase 2 trial of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer and without prior chemotherapy (jpn-201 study). Jpn Clin Oncol 2014; 44: 1216-1226.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of drug-induced adrenocortical insufficiency that was diagnosed as hypotension in a hemodialysis patient;Nihon Toseki Igakkai Zasshi;2020

2. Abiraterone-acetate;Reactions Weekly;2019-09